Literature DB >> 17668844

Dupuytren's disease: diagnosis and treatment.

Thomas H Trojian1, Stephanie M Chu.   

Abstract

Dupuytren's disease is a progressive condition that causes the fibrous tissue of the palmar fascia to shorten and thicken. The disease is common in men older than 40 years; in persons of Northern European descent; and in persons who smoke, use alcohol, or have diabetes. Patients present with a small, pitted nodule (or multiple nodules) on the palm, which slowly progresses to contracture of the fingers. The disease initially can be managed with observation and nonsurgical therapy. It will regress without treatment in approximately 10 percent of patients. Steroid injection into the nodule has been shown to reduce the need for surgery. Surgical referral should be made when metacarpophalangeal joint contracture reaches 30 degrees or when proximal interphalangeal joint contracture occurs at any degree. Timing of surgical intervention varies, but surgery is usually performed when the metacarpophalangeal joint contracture exceeds 40 degrees or when the proximal interphalangeal joint contracture exceeds 20 degrees. In-office percutaneous needle aponeurotomy is an alternative to surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17668844

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  7 in total

Review 1.  Trends in the Treatment of Dupuytren Disease in the United States Between 2007 and 2014.

Authors:  Marc D Lipman; Samuel Evan Carstensen; Dylan Nicole Deal
Journal:  Hand (N Y)       Date:  2016-05-03

2.  Dupuytren's disease: what dermatologists need to know.

Authors:  Camila Ribeiro Amadio; Barbara Machado Magalhães; Felipe Yazawa; Karine Simone
Journal:  An Bras Dermatol       Date:  2018 Sep-Oct       Impact factor: 1.896

3.  Multiple fibromas of tendon sheath: unusual presentation.

Authors:  Se Young Park; Seon Pil Jin; Bora Yeom; Shin Woo Kim; So Yun Cho; Jong Hee Lee
Journal:  Ann Dermatol       Date:  2011-09-30       Impact factor: 1.444

4.  Dupuytren's contracture: a retrospective database analysis to determine hospitalizations in the Netherlands.

Authors:  Jetty A Overbeek; Fernie Ja Penning-van Beest; Edith M Heintjes; Robert A Gerber; Joseph C Cappelleri; Steven Er Hovius; Ron Mc Herings
Journal:  BMC Res Notes       Date:  2011-10-12

Review 5.  Postapproval clinical experience in the treatment of Dupuytren's contracture with collagenase clostridium histolyticum (CCH): the first 1,000 days.

Authors:  Scott M Schulze; James P Tursi
Journal:  Hand (N Y)       Date:  2014-12

6.  Residual deformity versus recurrence following Dupuytren's palmar fasciectomy-a long term follow-up of 142 cases.

Authors:  Niranj Ganeshan Radhamony; Rajiv Ramachandran Nair; Sachith Sreenivasan; Sriganesh Walkay; Aditya Soni; Rahul Kakkar
Journal:  Ann Med Surg (Lond)       Date:  2022-01-01

7.  Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells.

Authors:  Linda Vi; Anna Njarlangattil; Yan Wu; Bing Siang Gan; David B O'Gorman
Journal:  BMC Musculoskelet Disord       Date:  2009-06-19       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.